drugset / Trial / NCT07503444
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to investigate the efficacy of fenfluramine hydrochloride (HCl) versus placebo in study participants with Rett syndrome (RTT).
Timeline
- Start
- 2026-07-14
- Primary completion
- 2029-02-06
- Completion
- 2031-08-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fenfluramine | Small molecule | — | Oral |